RedHill Biopharma annual ebitda
2018
2019
2020
2021
2022
2023
2024
2025
RedHill Biopharma EBITDA Growth & History (RDHL)
RedHill Biopharma's calculated EBITDA was −$7.7M for fiscal 2025.
View full RedHill Biopharma company overviewRedHill Biopharma annual ebitda history
| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$7.7M | $6.4M | — |
| 2024 | 2024-12-31 | −$14.0M | −$28.1M | — |
| 2023 | 2023-12-31 | $14.1M | $54.8M | — |
| 2022 | 2022-12-31 | −$40.7M | $38.5M | — |
| 2021 | 2021-12-31 | −$79.2M | −$17.2M | — |
| 2020 | 2020-12-31 | −$62.0M | −$19.8M | — |
| 2019 | 2019-12-31 | −$42.2M | −$3.2M | — |
| 2018 | 2018-12-31 | −$39.0M | — | — |
RedHill Biopharma quarterly ebitda
Q2.21
Q2.22
| Fiscal quarter | Period ended | EBITDA | Change | YoY change |
|---|---|---|---|---|
| Q2 2022 | 2022-06-30 | −$8.5M | $15.9M | — |
| Q2 2021 | 2021-06-30 | −$24.4M | — | — |
RedHill Biopharma ebitda trends
Over the last five fiscal years, RedHill Biopharma's ebitda increased from −$62.0M to −$7.7M, a change of $54.3M. The latest reported quarter, Q2 2022, shows −$8.5M.
About the metric
What EBITDA means
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
Calculation and source
How TickerStat calculates EBITDA
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review RedHill Biopharma source filings ↗Community posts
RedHill reports wider first-half loss amid commercial-portfolio transition
RedHill Biopharma ($RDHL) reported a first-half net loss of $6.1 million, compared with $4.1 million a year earlier, and no revenue from continuing operations. Operating cash use was $4.6 million, while the half-year cash balance stood at $ ...
